Children Now Eligible for Screening Test for Bacterium
FRIDAY, Feb. 24 (HealthDay News) -- The U.S. Food and Drug Administration has expanded approval for a breath test that screens for a common ulcer-causing germ, to include children aged 3 years to 17.
The Helicobacter pylori bacterium causes stomach inflammation (gastritis) and ulcers, and increases an infected person's risk of gastric cancer and a certain form of lymphoma. In a news release, the FDA said the BreathTak UBT test, approved for adults in 1996, is now sanctioned for children.
The U.S. Centers for Disease Control and Prevention estimates that more than two-thirds of the world's population is infected with the bacterium, abbreviated H. pylori, but most infected people never have symptoms, the FDA said.
The BreathTek UBT test was newly approved based on results from a multi-location clinical trial involving 176 children, the agency said.
The test is produced by Otsuka America Pharmaceutical, headquartered in Rockville, Md.
To learn more about H. Pylori, visit the CDC.Related Articles
- Some U.S. Clinical Trials May Fall Into Federal Regulation 'Gap'
March 04, 2014
- Eye-Catching Labels Urged for Fast-Tracked Antibiotics
March 02, 2014
Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.
Copyright ©2012 HealthDay. All rights reserved.